About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

RECRUITING

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

Multicenter Retrospective Observational Study Analyzing Infective Complications and the Clinical Outcome of Patients With Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin (INO-FIRST)

NCT06025682•Gruppo Italiano Malattie EMatologiche dell'Adulto

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Acute Lymphoblastic LeukemiaInfectionsBacterial Infections+4 more

Locations

1

Italy

Locations (1)

UOC Ematologia Fondazione Policlinico Universitario A.Gemelli

Roma, Italy

Key Dates

Start Date

April 4, 2024

Primary Completion Date

January 1, 2025

Completion Date

January 1, 2025

Last Updated

April 11, 2024

Related Studies

RECRUITINGEARLY Phase 1

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

NCT06735690

Acute Lymphoblastic Leukemia

Study of Mycobacterial Infections

NCT00018044

Mycobacterium Infections

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

NCT06074666

Acute Lymphoblastic Leukemia, Pediatric

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

RECRUITINGPhase 2

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

NCT07286370

Salmonella Infections

Diagnosis and Treatment of Leishmania Infections

NCT00344188

LeishmaniasisSkin Diseases, Parasitic+2 more

View all related studies

Contacts

Paola Fazi

CONTACT

0670390528 p.fazi@gimema.it

Enrico Crea

CONTACT

0670390514 e.crea@gimema.it

Sponsors

Lead Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 11, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions